Related Experiment Video
Updated: Sep 13, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
MicroRNA biosensors for cardiovascular disease detection
Asma Vafadar1, Sajad Alavimanesh2, Sepideh Babadi1
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
MicroRNAs (miRNAs) are key biomarkers for cardiovascular diseases (CVDs). Electrochemical biosensors offer a rapid, cost-effective method for detecting these miRNA biomarkers, improving early CVD diagnosis and patient outcomes.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of mortality.
- Early detection and intervention are critical for improving patient prognosis.
- MicroRNAs (miRNAs) play crucial roles in cardiovascular pathophysiology, acting as potential biomarkers.
Purpose of the Study:
- To review the application of miRNA-based electrochemical biosensors for cardiovascular disease detection.
- To highlight the significance of miRNAs in cardiovascular disorders like myocardial infarction, heart failure, and atherosclerosis.
- To discuss recent advancements in electrochemical biosensor technology for miRNA detection in biological samples.
Main Methods:
- Literature review of studies on miRNA biomarkers and electrochemical biosensors for CVDs.
- Keyword searches in PubMed, Scopus, and Web of Science.
- Analysis of nanomaterial-based electrochemical biosensor integration for miRNA detection.
Main Results:
- Electrochemical biosensors provide rapid, specific, and cost-effective detection of miRNA biomarkers.
- Nanomaterial integration enhances the sensitivity and performance of these biosensors.
- miRNA detection facilitates real-time monitoring of CVD progression and treatment response.
Conclusions:
- miRNA-based electrochemical biosensors show significant promise for early and accurate diagnosis of cardiovascular diseases.
- These biosensors represent a valuable tool for advancing molecular diagnostics in cardiology.
- Further integration of advanced nanomaterials can optimize biosensor performance for clinical applications.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
MicroRNAs

